NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 217 filers reported holding NPS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $7,561,000 | +48.5% | 211,373 | +7.9% | 0.03% | +45.5% |
| Q3 2014 | $5,091,000 | -29.0% | 195,826 | -9.7% | 0.02% | -24.1% |
| Q2 2014 | $7,169,000 | -30.3% | 216,902 | -36.9% | 0.03% | -38.3% |
| Q1 2014 | $10,281,000 | +12.4% | 343,511 | +14.1% | 0.05% | +23.7% |
| Q4 2013 | $9,143,000 | +69.5% | 301,167 | +77.7% | 0.04% | +58.3% |
| Q3 2013 | $5,393,000 | +120.3% | 169,528 | +4.6% | 0.02% | +84.6% |
| Q2 2013 | $2,448,000 | – | 162,108 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 424,175 | $12,695,000 | 5.06% |
| Opaleye Management Inc. | 150,000 | $4,490,000 | 3.32% |
| OAK RIDGE INVESTMENTS LLC | 2,795,331 | $83,664,000 | 2.10% |
| SCHOLTZ & COMPANY, LLC | 60,350 | $1,806,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 1,408,729 | $42,163,000 | 1.73% |
| First Light Asset Management, LLC | 79,099 | $2,367,000 | 1.68% |
| FCG ADVISORS, LLC | 71,146 | $2,129,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 166,970 | $4,997,000 | 1.50% |
| BENDER ROBERT & ASSOCIATES | 73,611 | $2,203,000 | 1.48% |
| Eventide Asset Management | 283,900 | $8,497,000 | 1.32% |